The recent nation-wide shortage of the arthritis drug, Tocilizumab, has highlighted the growing problem of prescription drug shortages in Australia and the vulnerability of our pharmaceutical supply chains. Patients, prescribers, and pharmacists alike are left in limbo when overseas pharmaceutical companies are unable to meet orders due to increased demand or disruption to manufacture or…
What Patients & Practitioners Are Saying
About Our Compounding Medicines